Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depression

Hyun-Ghang Jeong, Young-Hoon Ko, So Young Oh, Changsu Han, Taehee Kim, Sook Haeng Joe

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Introduction: Around 20% of patients with major depression experience residual symptoms. Ginseng has shown potential antidepressant effects in some animal studies and in patients with stress-related somatic symptoms. Therefore, we investigated the effectiveness and tolerability of Korean Red Ginseng adjuvant treatment in patients with residual symptoms of major depression. Methods: In this eight-week prospective study, 35 female outpatients aging from 18 to 65 years (45.1±9.5), who were remitted from major depression with residual symptoms, were given Korean Red Ginseng at doses of 3g/day. The Depression Residual Symptom Scale (DRSS) and Montgomery-Åsberg Depression Rating Scale (MADRS) were administrated to evaluate depressive symptoms. The general severity of symptoms was assessed by a clinician using the Clinical Global Impressions Scale for Severity (CGI-S). The Depression and Somatic Symptom Scale (DSSS) was also used to evaluate somatic symptoms in the subjects. This trial is registered at Clinical.gov, number NCT01496248. Results: Subjects reported significant decrease in depressive symptoms on the DRSS (P<0.05) and MADRS (P<0.01) decreased significantly over the eight-week period. The scores on the CGI-S, an objective measurement of symptoms, showed significant improvement in the severity of illness (P<0.001). Somatic symptoms on the DSSS also attenuated significantly during the study period (P<0.05). Discussion: These results suggest that Korean Red Ginseng is efficacious as an adjuvant treatment for patients experiencing residual symptoms of major depression. Future placebo-controlled research is required to confirm our results.

Original languageEnglish
Pages (from-to)330-336
Number of pages7
JournalAsia-Pacific Psychiatry
Volume7
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Panax
Depression
Therapeutics
Antidepressive Agents
Outpatients
Placebos
Medically Unexplained Symptoms
Prospective Studies

Keywords

  • Alternative treatment
  • Depression
  • Ginseng
  • Residual symptom

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depression. / Jeong, Hyun-Ghang; Ko, Young-Hoon; Oh, So Young; Han, Changsu; Kim, Taehee; Joe, Sook Haeng.

In: Asia-Pacific Psychiatry, Vol. 7, No. 3, 01.01.2015, p. 330-336.

Research output: Contribution to journalArticle

@article{7965d1864d9944eb845de6dc0a67e706,
title = "Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depression",
abstract = "Introduction: Around 20{\%} of patients with major depression experience residual symptoms. Ginseng has shown potential antidepressant effects in some animal studies and in patients with stress-related somatic symptoms. Therefore, we investigated the effectiveness and tolerability of Korean Red Ginseng adjuvant treatment in patients with residual symptoms of major depression. Methods: In this eight-week prospective study, 35 female outpatients aging from 18 to 65 years (45.1±9.5), who were remitted from major depression with residual symptoms, were given Korean Red Ginseng at doses of 3g/day. The Depression Residual Symptom Scale (DRSS) and Montgomery-{\AA}sberg Depression Rating Scale (MADRS) were administrated to evaluate depressive symptoms. The general severity of symptoms was assessed by a clinician using the Clinical Global Impressions Scale for Severity (CGI-S). The Depression and Somatic Symptom Scale (DSSS) was also used to evaluate somatic symptoms in the subjects. This trial is registered at Clinical.gov, number NCT01496248. Results: Subjects reported significant decrease in depressive symptoms on the DRSS (P<0.05) and MADRS (P<0.01) decreased significantly over the eight-week period. The scores on the CGI-S, an objective measurement of symptoms, showed significant improvement in the severity of illness (P<0.001). Somatic symptoms on the DSSS also attenuated significantly during the study period (P<0.05). Discussion: These results suggest that Korean Red Ginseng is efficacious as an adjuvant treatment for patients experiencing residual symptoms of major depression. Future placebo-controlled research is required to confirm our results.",
keywords = "Alternative treatment, Depression, Ginseng, Residual symptom",
author = "Hyun-Ghang Jeong and Young-Hoon Ko and Oh, {So Young} and Changsu Han and Taehee Kim and Joe, {Sook Haeng}",
year = "2015",
month = "1",
day = "1",
doi = "10.1111/appy.12169",
language = "English",
volume = "7",
pages = "330--336",
journal = "Asia-Pacific Psychiatry",
issn = "1758-5864",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depression

AU - Jeong, Hyun-Ghang

AU - Ko, Young-Hoon

AU - Oh, So Young

AU - Han, Changsu

AU - Kim, Taehee

AU - Joe, Sook Haeng

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Introduction: Around 20% of patients with major depression experience residual symptoms. Ginseng has shown potential antidepressant effects in some animal studies and in patients with stress-related somatic symptoms. Therefore, we investigated the effectiveness and tolerability of Korean Red Ginseng adjuvant treatment in patients with residual symptoms of major depression. Methods: In this eight-week prospective study, 35 female outpatients aging from 18 to 65 years (45.1±9.5), who were remitted from major depression with residual symptoms, were given Korean Red Ginseng at doses of 3g/day. The Depression Residual Symptom Scale (DRSS) and Montgomery-Åsberg Depression Rating Scale (MADRS) were administrated to evaluate depressive symptoms. The general severity of symptoms was assessed by a clinician using the Clinical Global Impressions Scale for Severity (CGI-S). The Depression and Somatic Symptom Scale (DSSS) was also used to evaluate somatic symptoms in the subjects. This trial is registered at Clinical.gov, number NCT01496248. Results: Subjects reported significant decrease in depressive symptoms on the DRSS (P<0.05) and MADRS (P<0.01) decreased significantly over the eight-week period. The scores on the CGI-S, an objective measurement of symptoms, showed significant improvement in the severity of illness (P<0.001). Somatic symptoms on the DSSS also attenuated significantly during the study period (P<0.05). Discussion: These results suggest that Korean Red Ginseng is efficacious as an adjuvant treatment for patients experiencing residual symptoms of major depression. Future placebo-controlled research is required to confirm our results.

AB - Introduction: Around 20% of patients with major depression experience residual symptoms. Ginseng has shown potential antidepressant effects in some animal studies and in patients with stress-related somatic symptoms. Therefore, we investigated the effectiveness and tolerability of Korean Red Ginseng adjuvant treatment in patients with residual symptoms of major depression. Methods: In this eight-week prospective study, 35 female outpatients aging from 18 to 65 years (45.1±9.5), who were remitted from major depression with residual symptoms, were given Korean Red Ginseng at doses of 3g/day. The Depression Residual Symptom Scale (DRSS) and Montgomery-Åsberg Depression Rating Scale (MADRS) were administrated to evaluate depressive symptoms. The general severity of symptoms was assessed by a clinician using the Clinical Global Impressions Scale for Severity (CGI-S). The Depression and Somatic Symptom Scale (DSSS) was also used to evaluate somatic symptoms in the subjects. This trial is registered at Clinical.gov, number NCT01496248. Results: Subjects reported significant decrease in depressive symptoms on the DRSS (P<0.05) and MADRS (P<0.01) decreased significantly over the eight-week period. The scores on the CGI-S, an objective measurement of symptoms, showed significant improvement in the severity of illness (P<0.001). Somatic symptoms on the DSSS also attenuated significantly during the study period (P<0.05). Discussion: These results suggest that Korean Red Ginseng is efficacious as an adjuvant treatment for patients experiencing residual symptoms of major depression. Future placebo-controlled research is required to confirm our results.

KW - Alternative treatment

KW - Depression

KW - Ginseng

KW - Residual symptom

UR - http://www.scopus.com/inward/record.url?scp=84937162671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937162671&partnerID=8YFLogxK

U2 - 10.1111/appy.12169

DO - 10.1111/appy.12169

M3 - Article

C2 - 25504813

AN - SCOPUS:84937162671

VL - 7

SP - 330

EP - 336

JO - Asia-Pacific Psychiatry

JF - Asia-Pacific Psychiatry

SN - 1758-5864

IS - 3

ER -